🕵️ Ernexa Therapeutics Inc. ($ERNAW)
SEC insider & ownership activity, last 12 months · CIK 748592 · every row links its SEC filing
Over the last 12 months insiders bought $2.0M with no open-market selling against it. Charles Cherington bought $2.0M in discretionary trades (Feb). Charles Cherington trimmed 37.9% → 34.7%. One red-flag 8-K in the window: Delisting notice (3.01), Mar 18, 2026.
Insider flow
1 buyer, $2.0M (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Charles Cherington | 2 | $2.0M | 0 | – | Feb 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Charles Cherington | 34.7% | 13D | Feb 10, 2026 | filing ↗ | |
| Freebird Partners LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Freebird Investments LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Curtis Huff | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Shameek Konar | 9.7% | 13G | May 13, 2026 | filing ↗ | |
| Victoria Konar | 9.7% | 13G | May 13, 2026 | filing ↗ | |
| Regolith Capital Investments LP | 9.7% | 13G | May 13, 2026 | filing ↗ | |
| Bleichroeder LP | 6.9% | 13G | May 14, 2026 | filing ↗ | |
| Bleichroeder Holdings LLC | 6.9% | 13G | May 14, 2026 | filing ↗ | |
| Andrew Gundlach | 6.9% | 13G | May 14, 2026 | filing ↗ | |
| John D. Halpern | 5.6% | 13G | May 15, 2026 | filing ↗ | |
| Katherine H. Halpern | 5.6% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 6, 2026 | filing ↗ |
| Other events (8.01) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |